MATRix-RICE Therapy and Autologous HSCT in Diffuse Large B-Cell Lymphoma With Secondary CNS Involvement
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
MATRix-RICE Therapy and Autologous Haematopoietic Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma With Secondary CNS Involvement (MARIETTA): An International, Single-Arm, Phase 2 Trial
Lancet Haematol 2021 Feb 01;8(2)e110-e121, AJM Ferreri, JK Doorduijn, A Re, MG Cabras, J Smith, F Ilariucci, M Luppi, T Calimeri, C Cattaneo, J Khwaja, B Botto, C Cellini, L Nassi, K Linton, P McKay, J Olivieri, C Patti, F Re, A Fanni, V Singh, JEC Bromberg, K Cozens, E Gastaldi, M Bernardi, N Cascavilla, A Davies, CP Fox, M Frezzato, W Osborne, AM Liberati, U Novak, R Zambello, E Zucca, K CwynarskiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.